Skip to content

Correlation between the predicted effect-site concentration and cerebrospinal fluid concentration of remimazolam

Correlation between the predicted effect-site concentration and cerebrospinal fluid concentration of remimazolam - Correlation between the predicted effect-site concentration and cerebrospinal fluid concentration of remimazolam

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000061870
Enrollment
40
Registered
2026-06-12
Start date
2026-06-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients aged 18 years or older with ASA physical status 1-3 who are undergoing spinal surgery requiring a dural incision

Interventions

None listed

Sponsors

Niigata University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients aged 18 years or older with ASA physical status 1-3 who are scheduled to undergo spinal surgery requiring a dural incision. 2) Patients who have provided written informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1)Patients with a history of hypersensitivity to any component of the administered drugs 2)Patients with acute angle-closure glaucoma 3)Patients with a history of neuromuscular disorders, including myasthenia gravis 4)Patients in shock 5)Patients with impaired consciousness 6)Patients with a history of drug dependence 7)Patients with hepatic impairment 8)Patients with a body mass index (BMI) > 35 kg/m2 or < 14 kg/m2 9)Patients under 18 years of age 10)Pregnant women 11)Patients with an ASA physical status of 4 or higher 12)Patients with cognitive impairment 13)Patients deemed ineligible by the investigator

Design outcomes

Primary

MeasureTime frame
Cerebrospinal fluid concentration of remimazolam at the time of dural incision.

Secondary

MeasureTime frame
Predicted effect-site concentration of remimazolam at the time of dural incision. Blood concentration of remimazolam at the time of dural incision. Blood and cerebrospinal fluid concentrations of CNS7054 at the time of dural incision. Bispectral Index (BIS) value.

Countries

Japan

Contacts

Public ContactYoshihiro Naito

Niigata University Graduate School of Medical and Dental Sciences Division of Anesthesiology

m10068yn@jichi.ac.jp025-227-2328

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026